Editorial
Survival in eteplirsen‐treated Duchenne Muscular Dystrophy patients: Are there benefits beyond steroids?
Muscle & Nerve · 2024
DOI: 10.1002/mus.28107 ↗At a glance
Editorial in Muscle & Nerve, 2024. Written by W Bryan Burnette. Institution: Vanderbilt University Medical Center, Nashville, Tennessee, USA. Major MEDLINE topics: Muscular Dystrophy, Duchenne. 9 references.
Abstract (original language)
Intet abstract tilgængeligt.
Subjects
MeSH terms (MEDLINE)
Muscular Dystrophy, DuchenneHumansMorpholinosMaleChildSteroids
Substances
eteplirsenMorpholinosSteroids
Authors and institutions
- Vanderbilt University Medical Center, Nashville, Tennessee, USA.
ORCID profiles: W Bryan Burnette
Cite
APA
Burnette, W. B. (2024). Survival in eteplirsen‐treated Duchenne Muscular Dystrophy patients: Are there benefits beyond steroids?. Muscle & Nerve. https://doi.org/10.1002/mus.28107
Vancouver
Burnette WB. Survival in eteplirsen‐treated Duchenne Muscular Dystrophy patients: Are there benefits beyond steroids?. Muscle & Nerve. 2024. doi:10.1002/mus.28107
BibTeX
@article{Burnette2024,
author = {Burnette, W Bryan},
title = {Survival in eteplirsen‐treated Duchenne Muscular Dystrophy patients: Are there benefits beyond steroids?},
journal = {Muscle & Nerve},
year = {2024},
doi = {10.1002/mus.28107}
}
EUVIMED